Clinical Trials Browser

Phase 1 × Non-Muscle Invasive Bladder Neoplasms × BCG Vaccine × Clear all

NCT01498172 2015-02-04

BCG Modulation of the recMAGE-A3 + AS15 ASCI Response in the Treatment of Non Muscle Invasive Bladder Cancer (NMIBC) Patients

Phase 1 Completed

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms